00_preface_Amyotrophic Lateral Sclerosis
00x_part1
01_Amyotrophic Lateral Sclerosis:
An Introduction to Treatment and Trials
02_Insights Arising from Gene Expression Profiling
in Amyotrophic Lateral Sclerosis
03_Dynamic Meta-Analysis as a Therapeutic
Prediction Tool for Amyotrophic
Lateral Sclerosis
04_In Vivo and In Vitro Models to Study Amyotrophic Lateral Sclerosis
05_Advantages and Pitfalls in
Experimental Models Of ALS
06_Electrophysiological Abnormalities in SOD1
Transgenic Models in Amyotrophic Lateral
Sclerosis: The Commonalities and Differences
07_Molecular and Electrical Abnormalities in the
Mouse Model of Amyotrophic Lateral Sclerosis
07x_part2
08_Role of Mitochondrial Dysfunction in Motor
Neuron Degeneration in ALS
09_Role of Neuronal Mitochondrial Metabolic
Phenotype in Pathogenesis of ALS
10_Mutant Cu/Zn-Superoxide Dismutase Induced
Mitochondrial Dysfunction in Amyotrophic
Lateral Sclerosis
11_Folding and Aggregation of
Cu, Zn-Superoxide Dismutase
12_Oxidative Modifications of Cu, Zn-Superoxide
Dismutase (SOD1) – The Relevance to
Amyotrophic Lateral Sclerosis (ALS)
13_Reactive Nitrogen Species in
Motor Neuron Apoptosis
14_Protein Aggregates in Pathological Inclusions
of Amyotrophic Lateral Sclerosis
15_The Kynurenine Pathway
15x_part3
16_The Astrocytic Contribution in ALS:
Inflammation and Excitotoxicity
17_Innate Immunity in ALS
18_The Role of TNF-Alpha in ALS: New Hypotheses
for Future Therapeutic Approaches
19_Stem Cell Application for Amyotrophic
Lateral Sclerosis: Growth Factor
Delivery and Cell Therapy
20_Glial Cells as Therapeutic Targets for ALS
20x_part4
21_Genetics of Amyotrophic Lateral Sclerosis
22_Genetics of Familial
Amyotrophic Lateral Sclerosis
23_A Major Genetic Factor at Chromosome 9p
Implicated in Amyotrophic Lateral Sclerosis
(ALS) and Frontotemporal Lobar Degeneration
(FTLD)
23x_part5
24_Multidisciplinary Rehabilitation in
Amyotrophic Lateral Sclerosis
25_Assessment and Management of Respiratory
Dysfunction in Patients with Amyotrophic
Lateral Sclerosis
26_Nutritional Care in Amyotrophic Lateral
Sclerosis: An Alternative for the Maximization of
the Nutritional State
27_How to Assess Disease’s Severity and Monitor
Patients with Amyotrophic Lateral Sclerosis:
Lessons From Neurophysiology
28_Protection of Motor Neurons in
Pre-Symptomatic Individuals Carrying SOD 1
Mutations: Results of Motor Unit Number
Estimation (MUNE) Electrophysiology
29_Communication Impairment in ALS Patients
Assessment and Treatment
30_Human Computer Interactions for Amyotrophic
Lateral Sclerosis Patients
31_Overview of Cognitive Function in ALS, with
Special Attention to the Temporal Lobe:
Semantic Fluency and Rating the
Approachability of Faces